Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,059 | 53,359 | 58,313 | 63,197 | 66,933 |
| Other current assets | 1,480 | 1,062 | 1,353 | 1,596 | 1,797 |
| TOTAL | $50,539 | $54,421 | $59,666 | $64,793 | $68,730 |
| Non-Current Assets | |||||
| PPE Net | 43 | 48 | 48 | 45 | 27 |
| Other Non-Current Assets | 432 | 455 | 478 | 500 | 426 |
| TOTAL | $475 | $503 | $526 | $545 | $453 |
| Total Assets | $51,014 | $54,924 | $60,192 | $65,338 | $69,183 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,014 | 1,117 | 1,131 | 2,185 | 1,578 |
| Accrued Expenses | 1,705 | 2,381 | 2,051 | 1,510 | 1,302 |
| TOTAL | $2,719 | $3,498 | $3,182 | $3,695 | $2,880 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 357 | 383 | 410 | 435 | 394 |
| TOTAL | $357 | $383 | $410 | $435 | $394 |
| Total Liabilities | $3,076 | $3,881 | $3,592 | $4,130 | $3,274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -176,748 | -173,476 | -167,800 | -163,088 | -158,254 |
| TOTAL | $47,938 | $51,043 | $56,600 | $61,208 | $65,909 |
| Total Liabilities And Equity | $51,014 | $54,924 | $60,192 | $65,338 | $69,183 |